NYSE · DOUG

Douglas Elliman Inc.

$1.74 +$0.03 (+1.75%) 1D After hours

Key Metrics

$155.45M
Market cap
31.54×
P/E · TTM
$993.99M
Revenue · TTM
$4.93M
Net income
EPS · TTM $0.06
Dividend yield
Free cash flow −$30.18M
Beta · 1Y 1.84
EBITDA · TTM $16.35M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 11
    The stock moved -11.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 11
  • Apr 1
    From its Jan 29 high, the share price fell 44%.

    Peak close $2.79 on Jan 29; trough close $1.56 on Apr 1. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -44%
  • Mar 13
    The stock moved -26.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 13

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$155.45M
Enterprise value
Shares outstanding90.9M
52-wk range$1.53 – $3.19
Avg volume · 20D688.5K
Net cash
Book value / share$1.99
IndustryReal Estate Agents & Managers (For Others)
ExchangeNYSE
About Douglas Elliman Inc.
IPO dateDec 17, 2021
Employees580

Douglas Elliman Inc is engaged in the real estate services business and seeks to acquire or invest in additional real estate services businesses.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E31.54
P/S0.16
P/FCF
EV/EBITDA
EV/Sales
Graham №$1.62

Profitability

Gross
Operating 0.8%
Net 0.5%
FCF -3.0%
ROE / ROIC 3.0% · 6.0%

Financial Health

Current ratio1.48
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$48.81M

Cash Flow · TTM

Operating CF −$27.60M
Capex −$2.58M
Free cash flow −$30.18M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

2.4
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

$1.62 vs $1.74
Trades 1.1× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings